Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Julphar
Moodys
McKinsey
Mallinckrodt
Novartis
Cerilliant
McKesson
AstraZeneca
Dow

Generated: August 18, 2017

DrugPatentWatch Database Preview

REGLAN Drug Profile

« Back to Dashboard

Which patents cover Reglan, and when can generic versions of Reglan launch?

Reglan is a drug marketed by Robins Ah, Ani Pharms, West-ward Pharms Int, and Meda Pharms. and is included in four NDAs. There are two patents protecting this drug.

The generic ingredient in REGLAN is metoclopramide hydrochloride. There are twelve drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the metoclopramide hydrochloride profile page.

Summary for Tradename: REGLAN

Patents:0
Applicants:4
NDAs:4
Suppliers / Packagers: see list3
Bulk Api Vendors: see list37
Clinical Trials: see list27
Patent Applications: see list50
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:REGLAN at DailyMed

Pharmacology for Tradename: REGLAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Robins Ah
REGLAN
metoclopramide hydrochloride
SOLUTION;ORAL018821-001Mar 25, 1983DISCNYesNo► Subscribe► Subscribe► Subscribe
Meda Pharms
REGLAN ODT
metoclopramide hydrochloride
TABLET, ORALLY DISINTEGRATING;ORAL021793-001Jun 10, 2005DISCNNoNo► Subscribe► SubscribeY ► Subscribe
West-ward Pharms Int
REGLAN
metoclopramide hydrochloride
INJECTABLE;INJECTION017862-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Meda Pharms
REGLAN ODT
metoclopramide hydrochloride
TABLET, ORALLY DISINTEGRATING;ORAL021793-002Jun 10, 2005DISCNNoNo► Subscribe► SubscribeY ► Subscribe
Ani Pharms
REGLAN
metoclopramide hydrochloride
TABLET;ORAL017854-002May 5, 1987ABRXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: REGLAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
West-ward Pharms Int
REGLAN
metoclopramide hydrochloride
INJECTABLE;INJECTION017862-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
West-ward Pharms Int
REGLAN
metoclopramide hydrochloride
INJECTABLE;INJECTION017862-004May 28, 1987► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Argus Health
Cantor Fitzgerald
Harvard Business School
Farmers Insurance
Cerilliant
Daiichi Sankyo
Citi
Julphar
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot